ofa vs fda semaglutide FDA's Removal of and the Evolving Tirzepatide Decisions: What Compounders Need to Know Drug compounders sue over weight

Injectable GLP-1 agonists like Ozempic (injectable) have the most consistent evidence for large weight loss

Beyond BMI criteria, ideal candidates are patients who have attempted lifestyle modifications (diet, exercise) without achieving adequate or sustained weight loss

Lyophilized (powder) peptides remain stable refrigerated for 12 to 24 months or frozen for years

Weight loss of this magnitude 1521% of body weight includes loss of lean tissue alongside fat

For topical use, results can vary and might take longer or be less noticeable

Your delivery includes detailed storage instructions tailored to your specific formulation